Proportion of isolates with decreased susceptibility or resistance in New Zealand
New Zealand: Proportion of isolates with decreased susceptibility or resistance was 0.1 in 2020. ◆ Volatile
Latest (2020)
0.1
Change on year
down 77.2%
World rank
11th
of 52 countries
All-time high
1.04
in 2013
All-time low
0
in 2009
Years of data
10
2009–2020
Proportion of isolates with decreased susceptibility or resistance in New Zealand, 2009–2020
Source: World Health Organization, Global Health Observatory.
Analysis
In 2020, proportion of isolates with decreased susceptibility or resistance in New Zealand stood at 0.1.
The figure is down 77.2% on the previous year and down 88.7% over five years.
Over the whole period, proportion of isolates with decreased susceptibility or resistance in New Zealand peaked at 1.04 in 2013 and was at its lowest, 0, in 2009.
That places New Zealand 11th out of 52 countries with data for 2020, putting it in the top quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Proportion of isolates with decreased susceptibility or resistance in New Zealand, year by year
| Year | Value | Change |
|---|---|---|
| 2009 | 0 | — |
| 2010 | 0 | — |
| 2011 | 0 | — |
| 2012 | 0 | — |
| 2013 | 1.04 | — |
| 2014 | 0.2309 | -77.8% |
| 2015 | 0.8881 | +284.5% |
| 2016 | 0.277 | -68.8% |
| 2017 | 0.4386 | +58.3% |
| 2020 | 0.1 | -77.2% |
New Zealand compared with similar countries
- New Zealand's 0.1 is below the median for East Asia & Pacific, which is 0.7752, 13% of the median. (11 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0 | 0 | 0 | 1 |
| 2010s | 0.3595 | 0 | 1.04 | 8 |
| 2020s | 0.1 | 0.1 | 0.1 | 1 |
Countries ranked near New Zealand
- 8 Bhutan 1 compare
- 9 Mongolia 0.7752 compare
- 10 Belgium 0.6 compare
- 12 Australia 0.01 compare
- 13 Korea 0 compare
- 13 Argentina 0 compare
- 13 Croatia 0
- 13 Pakistan 0 compare
- 13 Ireland 0 compare
- 13 Chile 0
- 13 Poland 0
- 13 Latvia 0
- 13 Slovenia 0 compare
- 13 Malta 0
- 13 Thailand 0 compare
- 13 United Kingdom of Great Britain and Northern Ireland 0
- 13 Colombia 0
- 13 Cyprus 0
- 13 Spain 0 compare
- 13 United States of America 0 compare
- 13 Paraguay 0
- 13 Belarus 0
- 13 Philippines 0 compare
- 13 Slovakia 0
- 13 Sweden 0
- 13 Greece 0 compare
- 13 France 0
- 13 Denmark 0
- 13 South Africa 0
- 13 Norway 0
- 13 India 0 compare
- 13 Dominican Republic 0
- 13 Austria 0 compare
- 13 Peru 0 compare
- 13 Côte d'Ivoire 0
- 13 Germany 0 compare
- 13 Hungary 0
- 13 Iceland 0
- 13 Sri Lanka 0
- 13 Italy 0
- 13 Panama 0
- 13 Portugal 0
- 13 Netherlands 0
- 13 Estonia 0
More health data for New Zealand
- Un projection of annual infant deaths, annual growth rate -2.94 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.4815 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,116 deaths per 1,000 people (2090)
- Number of infants who die before age 1 33 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -0.1187 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0277 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.018 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is proportion of isolates with decreased susceptibility or resistance in New Zealand?
- Proportion of isolates with decreased susceptibility or resistance in New Zealand was 0.1 in 2020, according to World Health Organization, Global Health Observatory.
- What is the highest proportion of isolates with decreased susceptibility or resistance recorded in New Zealand?
- The highest recorded value was 1.04 in 2013.
- What is the lowest proportion of isolates with decreased susceptibility or resistance recorded in New Zealand?
- The lowest recorded value was 0 in 2009.
- How does New Zealand rank for proportion of isolates with decreased susceptibility or resistance?
- New Zealand ranks 11th out of 52 countries with data for 2020.
- Where does this New Zealand data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).